(The following letter is from Dr. William Andrews, the founder of Sierra Sciences, a company that has been searching for telomerase activators and which has actually found 858 of them so far. This is an amazing company, completely serious and really on to something. An investment in them could pay off in a huge way. Please respond to Dr. Andrews if you are interested, and otherwise pass his letter on to someone else who might be. Thanks--David Bunnell.)
I am writing you because Sierra Sciences has suffered a sudden and unexpected loss of funding. We need $200,000 per month to keep the company operating until mid-2011, when we expect to become self-sufficient with revenue from product sales.
Sierra Sciences is poised to make world-altering breakthroughs in anti-aging medicine. It is no exaggeration to say that we are on the brink of actually curing the disease we call aging! Unfortunately, our current investors were both hit hard by the financial crisis. They can no longer maintain the funding that drives Sierra Sciences’ research.
Looking ahead, Sierra Sciences’ management realizes that in the current economic climate we will have to generate our funding ourselves. To this end, we have formed an alliance with a well-known and very successful manufacturer and retailer of natural products. They will be marketing our discoveries as anti-aging nutraceuticals. This alliance is expected to bring us enough revenue to support further nutraceutical research by mid-2011, and to support pharmaceutical research by mid-2012.
Yesterday, Sierra Sciences’ two investors informed me that they will soon cease all funding of the company. Without interim funding, we will lose not only our opportunity to profit from the nutraceutical market, but also our opportunity to develop our pharmaceutical discoveries into a cure for aging. This would be a tragedy for humanity, as well as a missed opportunity to create a multi-billion dollar industry.
The bottom line is that Sierra Sciences needs $200,000 per month as soon as possible. We will need this interim funding for 6-12 months, at which time we expect to become self-sufficient from nutraceutical sales. This investment would buy the investor significant ownership of the company.
My current investors have also mentioned that they would consider selling some or all of their equity stake in Sierra Sciences. They are still very interested in curing aging and still strongly believe in Sierra Sciences’ path. Together, they have invested just over $20 million and own a controlling interest in the company. They would welcome a conversation on this subject.
Please contact me if you would like to learn more about our situation. All my contact information is included with my signature below. Under my signature are links to various documents that go into more detail about the background of the science and Sierra Sciences’ progress towards a cure for aging.
William H. Andrews, Ph.D.
President & CEO
Sierra Sciences, LLC
“Cure Aging or Die Trying”
ph: 775-856-9500, ext. 108
cell and text: 775-530-1516
Where’s Bill? http://www.sierrasci.